French hospital market of bone substitutes for void filling 2011-2016
In the period, 2011 to 2016 the French market of bone substitutes (BS) for void filling progressed at a +6.7% 5-year CAGR reaching € 22 millions in 2016 …
French market of HIV drugs in 2017
Despite the introduction of new generics and the increasing pressure on prices of fixed-dose combinations (FDC), the French market of HIV drugs declined by only 2% in 2017 in comparison to 2016. Market volume remained …
France Coronary Stents Market 2011-2016: hospital activity, market by stent type, key players, market shares
Hospital activity (PTCA procedures)
Market by end user (public/private hospital) and by stent type (drug-eluting stents by active substance, bare-metal stents)
Key players and market share dynamics 2011-2016 …
French market of home medical nutrition (article in French)
Le marché français de la nutrition médicale à domicile a progressé à un rythme soutenu au cours des six dernières années, boosté par les facteurs démographiques et la montée en puissance de l’offre de soins à domicile.
Entre 2010 et 2015 …
French retail market of antidiabetic drugs in 2016
In 2016, the French market of reimbursed antidiabetic drugs valued 1.055 Euro billion in terms of manufacturers' revenue. The total diabetes drug related expenditure of the…
French retail market of EGFR tyrosine-kinase inhibitors for non-small cell lung cancer in 2016: a summary report.
In 2016, TARCEVA still remains the leader of the French EGFR TKI market with a market share of 53.9%. Launched in 2014, GIOTRIF have been taking shares of TARCEVA reaching a market share of 15.5% by the end 2016, whereas IRESSA seems to resist with a market share of 30.6% by the end 2016…
Pricing of expensive anticancer drugs combinations: a new price regulation mechanism in France
Concerned by rapidly increasing costs of new expensive drugs combinations, the French government issued last summer a guidance for implementation of a new price regulation mechanism for expensive medications used in association of one or more products…
SIR-SPHERES Y90, the first medical device for Selective Internal Radiation Therapy (SIRT) reimbursed in France
SIR-SPHERES Y90 manufactured by Sirtex Medical Ltd (Australia) and distributed by Sirtex Medical Europe GmbH (Germany) has been registered for reimbursement in France at the price €12,660. The product will be reimbursed to hospitals on top of DRG3…
French retail market of EGFR tyrosine-kinase inhibitors in non-small cells lung cancer: a summary report
See table of contents
Get the full report for 175€ (15 pages)
Company or organisation name
EU VAT registration number (only for EU companies)
United Arab Emirates
Other, please specify
By checking this box, I agree to the
Terms and Conditions
and accept to receive information on new products and services developed by FlashAdvice. I understand that FlashAdvice will never communicate my name and my email address to a third party unless it's required by law or by national security services. I am informed that I can unsubscribe from FlashAdvice emails at any moment.
GET THE REPORT
We have sent the link to this report to your email:
After payment confirmation we will send the download link of this report to your email:
If in 24h you have still not recieved our email please check your spam email folder or contact us at email@example.com
Please enter your name
Please enter your email address
The email is not in correct format.
You have to agree the terms and conditions.
Invoicing address is not entered or incomplete.